Specialty infusion therapy is one of the most complex — and costly — areas of healthcare. For patients managing autoimmune conditions, neurological disorders, hematologic diseases, and more, infusion treatments are often lifelong necessities. For employers and health plans, they represent some of the highest per-member costs in the benefits portfolio.
That's why we are excited to announce that InfuCare Rx® has joined the Tendo Marketplace as a national infusion care provider.
Tendo today announced a new agreement with InfuCare Rx®, a national infusion services provider, to expand access to high-quality, cost-effective infusion therapy through the Tendo Marketplace.
InfuCare Rx, one of the nation's largest independent providers of specialty infusion services, announced it has completed a recapitalization of the business through a strategic founder-led equity buyback. Guggenheim Investments served as the strategic capital partner on behalf of certain of its clients for this milestone transaction. This transaction underscores InfuCare Rx management’s long-term commitment to the firm’s vision and values.




